Interpharm Holdings Stock Price Prediction
| IPAH Stock | USD 0 0.00 0.00% |
Momentum 0
Sell Peaked
Oversold | Overbought |
Quarterly Revenue Growth (0.07) |
Using Interpharm Holdings hype-based prediction, you can estimate the value of Interpharm Holdings from the perspective of Interpharm Holdings response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Interpharm Holdings to buy its stock at a price that has no basis in reality. In that case, they are not buying Interpharm because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Interpharm Holdings after-hype prediction price | USD 0.0041 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Interpharm | Build AI portfolio with Interpharm Stock |
Interpharm Holdings After-Hype Price Prediction Density Analysis
As far as predicting the price of Interpharm Holdings at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Interpharm Holdings or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Interpharm Holdings, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Interpharm Holdings Estimiated After-Hype Price Volatility
In the context of predicting Interpharm Holdings' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Interpharm Holdings' historical news coverage. Interpharm Holdings' after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Interpharm Holdings' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Interpharm Holdings is very steady at this time. Analysis and calculation of next after-hype price of Interpharm Holdings is based on 3 months time horizon.
Interpharm Holdings Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Interpharm Holdings is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Interpharm Holdings backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Interpharm Holdings, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 1 Events / Month | 0 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0 | 0 | 0.00 |
|
Interpharm Holdings Hype Timeline
Interpharm Holdings is currently traded for 0. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Interpharm is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Interpharm Holdings is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company recorded a loss per share of 0.09. Interpharm Holdings had not issued any dividends in recent years. The entity had 1:5 split on the 19th of November 1997. Given the investment horizon of 90 days the next forecasted press release will be very soon. Check out Interpharm Holdings Basic Forecasting Models to cross-verify your projections.Interpharm Holdings Related Hype Analysis
Having access to credible news sources related to Interpharm Holdings' direct competition is more important than ever and may enhance your ability to predict Interpharm Holdings' future price movements. Getting to know how Interpharm Holdings' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Interpharm Holdings may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PXYN | Praxsyn Corp | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DNAG | DNAPrint Genomics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IMMB | Immunotech Laboratories | 0.00 | 2 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| USRM | US Stem Cell | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| JNHMF | Jack Nathan Medical | 0.00 | 0 per month | 0.00 | 0.1 | 0.00 | 0.00 | 82.61 | |
| SPPH | Spencer Pharmaceutical | 0.00 | 3 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MHTX | Manhattan Scients | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| REFG | Medical Cannabis Pay | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| INLB | Item 9 Labs | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CBGL | Cannabis Global | 0.00 | 0 per month | 0.00 | 0.09 | 0.00 | 0.00 | 150.00 |
Interpharm Holdings Additional Predictive Modules
Most predictive techniques to examine Interpharm price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Interpharm using various technical indicators. When you analyze Interpharm charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Interpharm Holdings Predictive Indicators
The successful prediction of Interpharm Holdings stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Interpharm Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Interpharm Holdings based on analysis of Interpharm Holdings hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Interpharm Holdings's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Interpharm Holdings's related companies. | 2010 | 2011 | 2024 | 2025 (projected) | Dividend Yield | 0.57 | 0.15 | 0.17 | 0.16 | Price To Sales Ratio | 1.9E-5 | 0.0111 | 0.01 | 0.0105 |
Story Coverage note for Interpharm Holdings
The number of cover stories for Interpharm Holdings depends on current market conditions and Interpharm Holdings' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Interpharm Holdings is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Interpharm Holdings' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Complementary Tools for Interpharm Stock analysis
When running Interpharm Holdings' price analysis, check to measure Interpharm Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Interpharm Holdings is operating at the current time. Most of Interpharm Holdings' value examination focuses on studying past and present price action to predict the probability of Interpharm Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Interpharm Holdings' price. Additionally, you may evaluate how the addition of Interpharm Holdings to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |